Free Access
Volume 54, Number 3, July-September 2019
Page(s) 181 - 185
Published online 02 July 2019
  • Ahmed BA, Connolly BL, Shroff P, Chong AL, Gordon C, Grant R, Greenberg ML, Thomas KE. 2010. Cumulative effective doses from radiologic procedures for pediatric oncology patients. Pediatrics 126(4): e851–e858. [CrossRef] [PubMed] [Google Scholar]
  • Almohiy H. 2014. Paediatric computed tomography radiation dose: a review of the global dilemma. World J. Radiol. 6(1): 1–6. [CrossRef] [PubMed] [Google Scholar]
  • Armao D, Smith JK. 2014. The health risks of ionizing radiation from computed tomography. N. C. Med. J. 75(2): 126–131. [Google Scholar]
  • Dunn M, Hillier MC, Lewis MA, Shrimpton PC. 2005. Doses from computed tomography (CT) examinations in the UK: 2003 review. Chilton: National Radiological Protection Board. [Google Scholar]
  • Federico SM, Brady SL, Pappo A, Wu J, Mao S, McPherson VJ, Young A, Furman WL, Kaufman R, Kaste S. 2015. The role of chest-computed tomography (CT) as a surveillance tool in children with high-risk neuroblastoma. Pediatr. Blood Cancer 62(6): 976–981. [Google Scholar]
  • ICRP. 1987. Radiation dose to patients from radiopharmaceuticals. Ann. ICRP 18(1–4): 1–29. [CrossRef] [PubMed] [Google Scholar]
  • ICRP. 1991. 1990 Recommendations of the International Commission on Radiological Protection. Ann. ICRP 21(1–3): 1–201. [Google Scholar]
  • Miglioretti DL, Johnson E, Williams A, Greenlee RT, Weinmann S, Solberg LI, Feigelson HS, Roblin D, Flynn MJ, Vanneman N, Smith-Bindman R. 2013. The use of computed tomography in pediatrics and the associated radiation exposure and estimated cancer risk. JAMA Pediatr. 167(8): 700–707. [CrossRef] [PubMed] [Google Scholar]
  • Monclair T, Brodeur GM, Ambros PF, Brisse HJ, Cecchetto G, Holmes K, Kaneko M, London WB, Matthay KK, Nuchtern JG, von Schweinitz D, Simon T, Cohn SL, Pearson ADJ. 2009. The International Neuroblastoma Risk Group (INRG) staging system: an INRG Task Force report. J. Clin. Oncol. 27(2): 298–303. [CrossRef] [PubMed] [Google Scholar]
  • Mueller WP, Coppenrath E, Pfluger T. 2013. Nuclear medicine and multimodality imaging of pediatric neuroblastoma. Pediatr. Radiol. 43(4): 418–427. [CrossRef] [PubMed] [Google Scholar]
  • Owens C, Li BK, Thomas KE, Irwin MS. 2016. Surveillance imaging and radiation exposure in the detection of relapsed neuroblastoma. Pediatr. Blood Cancer 63(10): 1786–1793. [Google Scholar]
  • Özyörük D, Emir S, Demir HA, Kabaçam GB, Tunç B. 2017. Total estimated effective doses from radiologic imaging modalities of children with cancer: a single center experience. World J. Pediatr. 13(3): 242–247. [CrossRef] [PubMed] [Google Scholar]
  • Pfluger T, Piccardo A. 2017. Neuroblastoma: MIBG imaging and new tracers. Semin. Nucl. Med. 47(2): 143–157. [CrossRef] [PubMed] [Google Scholar]
  • Robbins E. 2008. Radiation risks from imaging studies in children with cancer. Pediatr. Blood Cancer 51(4): 453–457. [Google Scholar]
  • Siegel JA, Pennington CW, Sacks B. 2017. Subjecting radiologic imaging to the linear no-threshold hypothesis: a non sequitur of non-trivial proportion. J. Nucl. Med. 58(1): 1–6. [CrossRef] [PubMed] [Google Scholar]
  • Valentin J, ed. 1999. Radiation dose to patients from radiopharmaceuticals: Addendum 2 to ICRP publ. 53; also includes addendum 1 to ICRP publ. 72. Oxford: Pergamon Press. [Google Scholar]
  • Ward E, DeSantis C, Robbins A, Kohler B, Jemal A. 2014. Childhood and adolescent cancer statistics, 2014 . CA Cancer J. Clin. 64(2): 83–103. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.